- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Apr 23, 2026 | 43.15M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2026 | 43.34M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2025 | 44.51M sh |
| Stock Repurchased | Q1 2024 · Mar 31, 2026 | $7.28M |
| Stock Repurchased | Q1 2024 · Mar 31, 2025 | $16.92M |
| Dividends Paid | Q1 2024 · Mar 31, 2026 | $719K |
| Dividends Paid | Q1 2024 · Mar 31, 2025 | $719K |
| Capex | Q1 2024 · Mar 31, 2026 | $1.23M |
| Capex | Q1 2024 · Mar 31, 2025 | $713K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2026 | $56.27M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2025 | $68.75M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2026 | $144.93M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2025 | $154.59M |
| Stockholders Equity | Q1 2024 · Mar 31, 2026 | $1.92B |
| Stockholders Equity | Q1 2024 · Dec 31, 2025 | $1.86B |
| Stockholders Equity | Q1 2024 · Mar 31, 2025 | $1.69B |
| Stockholders Equity | Q1 2024 · Dec 31, 2024 | $1.63B |
| Total Liabilities | Q1 2024 · Mar 31, 2026 | $542.51M |
| Total Liabilities | Q1 2024 · Dec 31, 2025 | $601.78M |
| Total Assets | Q1 2024 · Mar 31, 2026 | $2.53B |
| Total Assets | Q1 2024 · Dec 31, 2025 | $2.53B |
| Eps Diluted | Q1 2024 · Mar 31, 2026 | $1.39 |
| Eps Diluted | Q1 2024 · Mar 31, 2025 | $1.67 |
| Eps Basic | Q1 2024 · Mar 31, 2026 | $1.40 |
| Eps Basic | Q1 2024 · Mar 31, 2025 | $1.67 |
| Sga Expense | Q1 2024 · Mar 31, 2026 | $52.59M |
| Sga Expense restated | Q1 2024 · Mar 31, 2025 | $52.57M |
| Net Income | Q1 2024 · Mar 31, 2026 | $60.95M |
| Net Income | Q1 2024 · Mar 31, 2025 | $75.06M |
| Gross Profit | Q1 2024 · Mar 31, 2026 | $131.72M |
| Gross Profit | Q1 2024 · Mar 31, 2025 | $155.79M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2026 | $324.27M |
| Cost Of Revenue restated | Q1 2024 · Mar 31, 2025 | $328.67M |
| Revenue | Q1 2024 · Mar 31, 2026 | $465.49M |
| Revenue restated | Q1 2024 · Mar 31, 2025 | $489.32M |